News

Results   21-28 of 28

A large scale clinical trial is in progress to determine the benefit of BSG’s microEEG® System in the Emergency Department

May, 2011

A large scale clinical trial is in progress to determine the benefit of BSG’s microEEG® System in the Emergency Department, Diagnostic Utility of Emergency Electroencephalography in Identifying Non-Convulsive Seizures and Subclinical Status Epilepticus in Patients with Altered Mental Status. View More

The microEEG® System is currently used in a NYU study to record EEG signals in subjects before and after exercise

March, 2011

The microEEG® System is currently used in a NYU study to record EEG signals in subjects before and after exercise, with the intention of assessing particular EEG patterns that are expected to synchronize better in the post exercise period. These findings have important practical implications for the use of the microEEG® System in assessing various cognitive functions. The Effects of Acute Aerobic Exercise on Cognition and Neural Signals in Humans.

Dr. André Fenton broadcasted by Nova

February, 2011

Nova broadcasts a profile on neurobioligist and BSG President Dr. André Fenton View More

BSG awarded a $60K Biotechnology Tax Credit

February, 2011

BSG was awarded a $60K Biotechnology Tax Credit from New York City, an award which will help support further development of the microEEG® technology.

BSG received two $244K grant awards

November, 2010

BSG received two $244K grant awards from the IRS Qualifying Therapeutic Discovery Project to support development of BSG’s microEEG® System for the Emergency Department and its home epilepsy monitoring system.

BSG closed its C round of financing

April, 2010

BSG closed its C round of financing from a group of international private investors which includes leading financial, legal and marketing industry executives.

BSG received a 3 year, $3M grant award

March, 2010

BSG received a 3 year, $3M grant award from the National Institutes of Neurological Disorders and Stroke of the National Institutes of Health to conduct clinical trials of its microEEG® system in the Emergency Department.

The New York Times article profiles BSG’s President Dr. André Fenton’s research

April, 2009

Brain Researchers Open Door to Editing Memory. The New York Times article profiles BSG’s President Dr. André Fenton’s research of a drug that inhibits PKM zeta, a substance that the brain apparently needs to retain much of its learned information. View More